Loading
IARC estimates 27,511 new cancer cases and 16,190 cancer deaths in Angola in 2024; the commonest new cancers are breast, cervix uteri and prostate. This page is assembled automatically from OnCo's data, and says what OnCo does not yet hold.
| Site | New cases | Rate | OnCo page |
|---|---|---|---|
| Breast | 4,614 | 37.1 | Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer, HER2-positive breast cancer |
| Cervix uteri | 3,361 | 30.5 | Cervical cancer |
| Prostate | 2,217 | 32.4 | Prostate cancer |
| Colorectum | 1,172 | 5.1 | Colorectal cancer |
| Leukaemia | 1,159 | 3.1 | Acute myeloid leukaemia, Acute lymphoblastic leukaemia, Chronic lymphocytic leukaemia |
| Non-Hodgkin lymphoma | 981 | 3.1 | Non-Hodgkin lymphoma (all types), Diffuse large B-cell lymphoma |
| Kaposi sarcoma | 850 | 3.5 | Kaposi sarcoma |
| Liver and intrahepatic bile ducts | 834 | 3.9 | Hepatocellular carcinoma |
| Trachea, bronchus and lung | 810 | 4.7 | Lung cancer (all types), Non-small-cell lung cancer, Small-cell lung cancer |
| Larynx | 756 | 3.8 |
| Site | Deaths | Rate | OnCo page |
|---|---|---|---|
| Breast | 2,139 | 18.1 | Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer, HER2-positive breast cancer |
| Cervix uteri | 2,058 | 19.1 | Cervical cancer |
| Prostate | 1,355 | 20.0 | Prostate cancer |
| Leukaemia | 745 | 2.1 | Acute myeloid leukaemia, Acute lymphoblastic leukaemia, Chronic lymphocytic leukaemia |
| Liver and intrahepatic bile ducts | 735 | 3.6 | Hepatocellular carcinoma |
| Trachea, bronchus and lung | 734 | 4.3 | Lung cancer (all types), Non-small-cell lung cancer, Small-cell lung cancer |
| Oesophagus | 647 | 3.4 | Oesophageal cancer |
| Colorectum | 627 | 3.0 | Colorectal cancer |
| Brain, central nervous system | 590 | 1.6 | Glioma & glioblastoma |
| Stomach | 546 | 3.0 | Gastric & gastro-oesophageal junction cancer |
No trial record in OnCo lists a site in Angola. OnCo reads sites from ClinicalTrials.gov; studies registered only elsewhere are searchable through the WHO International Clinical Trials Registry Platform.
OnCo holds no institution, company or person in Angola.
OnCo records approvals for United States, European Union, United Kingdom, Japan, China, Australia and India. Angola is not one of them, so no approval in OnCo speaks for it. See the approvals by region matrix for what is held.
A deep dive for Angola is ranked 59 of 60 in the country coverage queue (November 2026), which ranks countries without a page by cases, deaths, research output and population. Know a source? Suggest an edit.